Agilent Technologies acquires Biocare Medical
Agilent Technologies agreed to acquire Biocare Medical. Reported deal value: $950M. Status: Announced. Sector: Life sciences. Target headquarters context: Pacheco, California, United States.
This page summarizes publicly available information about the transaction as of 2026-03-09. Figures and status may change as filings and press coverage update.
By Sahil PandeyLife sciences firm Agilent Technologies NYSE:A said on Monday that it will acquire privately held clinical pathology firm Biocare Medical in an all- cash deal valued at $ 950 million, sending its shares up about 1% in the premarket trading. Agilent said Biocare tissue diagnostic prod…
Deal timeline
This transaction is classified in Life sciences with a reported deal value of $950M. Figures and status may change as sources update.